| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
| 05/19/2011 | WO2011058763A1 Aminothiazine or aminooxazine derivative having amino linker |
| 05/19/2011 | WO2011058193A1 [1,5]-diazocin derivatives |
| 05/19/2011 | WO2011057973A1 Oxazoline derivatives for treatment of cns disorders |
| 05/19/2011 | WO2011057935A1 3-(3,4-dihydro-2h-benzo [1,4]oxazin-6-yl)-1h-pyrimidin-2,4-dione compounds as herbicides |
| 05/19/2011 | WO2011057892A1 2,3-dihydrobenzoxazine and 2,3-dihydrobenzothiazine derivates as hif-inhibitors for the treatment of cancer and inflammatory diseases |
| 05/19/2011 | WO2010111634A3 Renin inhibitors |
| 05/19/2011 | US20110118473 Process for converting 9-dihydro-13acetylbaccatin iii paclitaxel and docetaxel |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118311 Azole compound |
| 05/19/2011 | US20110118290 Novel Amides and Thioamides as Pesticides |
| 05/19/2011 | US20110118282 Soluble Guanylate Cyclase Activators |
| 05/19/2011 | US20110118263 Benzothiophene alkanol piperazine derivatives and their use as antidepressant |
| 05/19/2011 | US20110118262 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors |
| 05/19/2011 | US20110118261 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 05/19/2011 | US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group |
| 05/19/2011 | US20110118259 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/19/2011 | US20110118258 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 05/19/2011 | US20110118257 Novel kinase modulators |
| 05/19/2011 | US20110118253 5-methyl-1-(naphthalen-2-yl)-1h-pyrazoles useful as sigma receptor inhibitors |
| 05/19/2011 | US20110118252 Substituted amide derivatives and methods of use |
| 05/19/2011 | US20110118250 Beta-secretase modulators and methods of use |
| 05/19/2011 | US20110118248 Heteroaryl sulfonamides and CCR2/CCR9 |
| 05/19/2011 | US20110118246 Novel Compounds |
| 05/19/2011 | US20110118245 Raf kinase modulator compounds and methods of use thereof |
| 05/19/2011 | US20110118244 Factor xa inhibitors |
| 05/19/2011 | US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2 |
| 05/19/2011 | US20110118236 Heterocyclic compound |
| 05/19/2011 | US20110118234 Urea Compounds as Gamma Secretase Modulators |
| 05/19/2011 | US20110118233 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 05/19/2011 | US20110118232 Pyrimidine compounds and use thereof |
| 05/19/2011 | US20110118221 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use |
| 05/19/2011 | US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases |
| 05/19/2011 | US20110117158 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives |
| 05/19/2011 | US20110117055 Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds |
| 05/19/2011 | CA2780772A1 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 05/19/2011 | CA2780568A1 Oxazoline derivatives for treatment of cns disorders |
| 05/19/2011 | CA2780433A1 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 05/19/2011 | CA2779088A1 [1,5]-diazocin derivatives |
| 05/18/2011 | EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3 |
| 05/18/2011 | EP2322520A1 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia |
| 05/18/2011 | EP2321862A1 Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same |
| 05/18/2011 | EP2321308A1 Piperidine gpcr agonists |
| 05/18/2011 | EP2321307A1 Tricyclic alkylaminomethyloxazolidinone derivatives |
| 05/18/2011 | EP2321306A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 05/18/2011 | EP2321305A1 Heterocyclic gpcr agonists |
| 05/18/2011 | EP2321303A2 Compounds that modulate intracellular calcium |
| 05/18/2011 | EP2321301A1 New heterocyclic carboxamides for use as thrombin inhibitors |
| 05/18/2011 | EP2321289A1 Selective glycosidase inhibitors and uses thereof |
| 05/18/2011 | EP2321288A1 Oxazole derivatives useful as inhibitors of faah |
| 05/18/2011 | EP2321287A1 4,5-dihydro-oxazol-2-yl derivatives |
| 05/18/2011 | EP2321285A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 05/18/2011 | EP2321283A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 05/18/2011 | EP2321274A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 05/18/2011 | EP2099759B1 Antibacterial quinoline derivatives |
| 05/18/2011 | EP2091949B1 Indole derivatives as s1p1 receptor agonists |
| 05/18/2011 | EP2079709B1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 05/18/2011 | EP2069339B1 Substituted piperidinophenyl oxazolidinones |
| 05/18/2011 | EP1848709B1 Novel salt form of a dopamine agonist |
| 05/18/2011 | EP1373210B1 Heterocyclic diamide invertebrate pest control agents |
| 05/18/2011 | CN1720225B N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 05/18/2011 | CN102066366A Novel substituted pyridin-2-ones and pyridazin-3-ones |
| 05/18/2011 | CN102066360A Quinoline or isoquinoline substituted P2X7 antagonists |
| 05/18/2011 | CN102066345A Oxazolidine derivatives as NMDA antagonists |
| 05/18/2011 | CN102066344A Methods of preparing imidazole-based bicyclic compounds |
| 05/18/2011 | CN102066340A 2, 6-diamino-pyrimidin- 5-yl-carboxamides as SRK or JAK kinases inhibitors |
| 05/18/2011 | CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors |
| 05/18/2011 | CN102066335A Substituted pyrimidin-5-carboxamides 281 |
| 05/18/2011 | CN102066326A Pyridone compound |
| 05/18/2011 | CN102066325A Heteroaromatic monoamides as orexinin receptor antagonists |
| 05/18/2011 | CN102066324A Fungicidal pyridines |
| 05/18/2011 | CN102066323A Novel estrogen receptor ligands |
| 05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
| 05/18/2011 | CN102066321A Pyrrolidine derivatives as NK2 receptor antagonists |
| 05/18/2011 | CN102060852A Quinoline complexes, preparation method thereof, quinoline complex-containing catalyst and use of catalyst in catalysis of vinyl polymerization |
| 05/18/2011 | CN102060792A 2'-aminochalcone-zole compounds, pyrazoline and cyclopropyl azole derivatives thereof and preparation method and applications of compounds |
| 05/18/2011 | CN102060772A N-(4-substituted phenyl)-1H-3-pyrazolecarboxamide cyclin dependent kinase 2 inhibitors and application thereof |
| 05/18/2011 | CN102060765A Tetrahydroisoquinoline derivative, preparation method and application thereof |
| 05/18/2011 | CN101146530B 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 05/17/2011 | US7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases |
| 05/17/2011 | US7943649 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors |
| 05/17/2011 | US7943645 Piperidine compounds for use as orexin receptor antagonist |
| 05/17/2011 | US7943611 Imidazo[1,2-A]pyridin-3-yl-acetic acid hydrazides, processes, for their preparation and pharmaceutical uses thereof |
| 05/17/2011 | US7943607 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 05/17/2011 | US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/17/2011 | US7943312 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 05/17/2011 | CA2473790C 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 05/12/2011 | WO2011056652A1 Imidazole derivatives as ido inhibitors |
| 05/12/2011 | WO2011055770A1 Fused heterocyclic compound |
| 05/12/2011 | WO2011055649A1 Crystal forms of sulfonylurea compound and method for producing the same |
| 05/12/2011 | WO2011055188A1 An improved process for the preparation of iloperidone |
| 05/12/2011 | WO2011054841A1 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 05/12/2011 | WO2010093650A3 Compositions and methods for controlling nematodes |
| 05/12/2011 | WO2008079988A9 Quinazolines for pdk1 inhibition |
| 05/12/2011 | US20110112301 Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol |
| 05/12/2011 | US20110112158 Benzisoxazole analogs as glycogen synthase activators |
| 05/12/2011 | US20110112157 Process for the preparation of zolmitriptan, salts and solvates thereof |
| 05/12/2011 | US20110112143 Allosteric modulators of metabotropic glutamate receptors |
| 05/12/2011 | US20110112142 Novel estrogen receptor ligands |
| 05/12/2011 | US20110112120 Heteromonocyclic compound and use thereof |